CLINICAL TRIALS PROFILE FOR PERIOCHIP
✉ Email this page to a colleague
All Clinical Trials for PERIOCHIP
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00425451 ↗ | The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis | Completed | Dexcel Pharma Technologies Ltd. | Phase 2 | 2008-08-01 | The purpose of this study is to determine the effect of the placement of a PerioChip Plus (flurbiprofen/chlorhexidine - FBP/CHX) formulation versus PerioChip (chlorhexidine) formulation versus Flurbiprofen Chip formulation versus Placebo Chip formulation on probing pocket depth (PPD) |
NCT01040286 ↗ | The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis | Completed | Dexcel Pharma Technologies Ltd. | Phase 2 | 2009-08-01 | The purpose of the study is to assess efficacy and safety of Flurbiprofen Chip versus Chlorhexidine chip (Periochip®) in therapy of adult chronic periodontitis. |
NCT01079663 ↗ | The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis | Completed | Dexcel Pharma Technologies Ltd. | Phase 2 | 2010-03-01 | The purpose of the study is to assess the efficacy and the safety of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis. |
NCT01249846 ↗ | The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis | Completed | Dexcel Pharma Technologies Ltd. | Phase 3 | 2010-12-01 | The purpose of this study is to assess the efficacy and the safety of Chlorhexidine Gluconate Chip (PerioChip®) in frequent treatment versus routine treatment in therapy of adult chronic periodontitis. |
NCT02080403 ↗ | The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis | Completed | Dexcel Pharma Technologies Ltd. | Phase 3 | 2014-07-01 | The objective of the study is to assess the efficacy and safety of PerioChip® (Chlorhexidine gluconate chip) in the treatment of patients with Peri-implantitis. The hypothesis of the study is that PerioChip® in adjunct to mechanical subgingival debridement is more effective in the treatment of peri-implantitis when compared to the common method of mechanical subgingival debridement alone. The primary efficacy measure will be the reduction in probing pocket depth at 6 months as measured at sites of qualifying target implant. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PERIOCHIP
Condition Name
Clinical Trial Locations for PERIOCHIP
Trials by Country
Clinical Trial Progress for PERIOCHIP
Clinical Trial Phase
Clinical Trial Sponsors for PERIOCHIP
Sponsor Name